Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,020 public trials 2,031 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

NCT06425198

Conditions
Digestive System Diseases, Healthy Participants, Hemic and Lymphatic Diseases, +11 more
Locations
  • Local Institution - 0001 Miami Lakes, Florida, United States
  • Local Institution - 0003 Orlando, Florida, United States
  • Local Institution - 0002 Tampa, Florida, United States
  • Local Institution - 0004 San Antonio, Texas, United States
View Trial Details
Completed

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

NCT03870633

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +23 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
View all 116 locations
View Trial Details
Completed

A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL

NCT03467373

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama Medical Center Birmingham, Alabama, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Fox Chase-Temple Cancer Center Philadelphia, Pennsylvania, United States
  • Peter Maccallum Cancer Centre Melbourne, Victoria, Australia
View all 22 locations
View Trial Details
Completed

Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients

NCT02990338

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • BRCR Medical Center Inc. Site Number : 8400002 Plantation, Florida, United States
  • Dana Farber Site Number : 8400006 Boston, Massachusetts, United States
  • Investigational Site Number : 0360004 St Leonards, New South Wales, Australia
  • Investigational Site Number : 0360001 Waratah, New South Wales, Australia
View all 111 locations
View Trial Details

Related conditions